Nurse Practitioner in Williamsburg, PA Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Angela Muri, CRNP-PMHNP Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 202 Cove Forge Rd, Williamsburg, PA 16693 Phone: 814-555-0149 |
 Mr. Kevin Edward Mckinney, CRNP Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 202 Cove Forge Rd, Williamsburg, PA 16693 Phone: 814-626-8663 Fax: 814-832-2345 |
News Archive
NCCN publishes new informational resources on health and wellness for cancer survivors
Today, the National Comprehensive Cancer Network announced the publication of new, free informational resources on health and wellness for cancer survivors.
Scientists identify two new key players involved in development of prostate cancer
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
State roundup: Georgia's child-only insurance policies; N.Y. exchange impasse
The Senate's Republican majority refused to agree to create a "health exchange," or state-based health insurance market required under President Barack Obama's health care overhaul, for individuals and small businesses to insure more Americans.
More companies are using HighRoads' procurement services to secure competitive healthcare coverage
As health care reform continues to negatively impact businesses' bottom line, HighRoads, the industry leader in employer health care regulation compliance, is finding an increasing number of companies using HighRoads' procurement and renewal service to secure more competitively priced plans.
Novartis' JUMP study reinforces safety, efficacy of Jakavi (ruxolitinib) for myelofibrosis treatment
Novartis today announced data from the largest clinical trial of myelofibrosis patients treated with Jakavi (ruxolitinib), supporting the safety profile and efficacy benefit as measured in primary and secondary endpoints respectively.
› Verified 6 days ago